Myomectomy for Fibroids during Cesarean Section: A Randomized Controlled Trial
| Autor: | Shabana, Ayman A., Sayyed, Tarek M., Rezk, Mohamed A., Nassar, Sara M., Solyman, Ayman Elsayed |
|---|---|
| Rok vydání: | 2021 |
| Předmět: | |
| Zdroj: | Egyptian Journal of Hospital Medicine; Vol. 86 No. 1 (2022); 9-16 |
| ISSN: | 2090-7125 1687-2002 |
| DOI: | 10.21608/ejhm.2021.209970 |
| Popis: | Background: There is a considerable debate about the management of myoma during cesarean section (CS). Recently, several studies indicated the safety and feasibility of undertaking myomectomy during CS.Objectives: To evaluate the safety, accessibility, and short-term morbidity of myomectomy for fibroids during cesarean section.Patients and Methods: This was a randomized controlled trial that included 72 patients who were admitted to the Obstetrics & Gynecology Department, Menoufia University Hospital with uterine fibroids during pregnancy; who were randomly allocated equally into a group of cesarean myomectomy (CM; n=36) and another group of CS only (n=36). The operative events and the outcome were recorded and analyzed.Results: CM group showed a longer duration of surgery and longer hospital stay, higher amount of blood loss, and higher mean pain sores, with a highly statistically significant difference (p = 0.000). No cases in both groups required blood transfusion or ICU admission. No statistically significant differences were noted between both groups as regards the fetal outcome measures (p=0.583 & 0.601).Conclusion: CM is safe and applicable in selected cases without deleterious maternal complications. Special precautions ought to be paid during the procedure, particularly in the intramural type and with large fibroids. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|